[{"NetIncomeLoss_1_Q2_USD":-81351000.0,"OperatingLeaseLiability_0_Q2_USD":51271000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":38928000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":19307000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":150571.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":153751.0,"CommitmentsAndContingencies_0_Q2_USD":null,"LiabilitiesNoncurrent_0_Q2_USD":47843000.0,"AccruedLiabilitiesCurrent_0_Q2_USD":34192000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":33000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsAmortizedCostBasis_0_Q2_USD":573549000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-81954000.0,"Depreciation_2_Q2_USD":700000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_2_Q2_USD":14000.0,"Depreciation_1_Q2_USD":300000.0,"StockIssuedDuringPeriodValueNewIssues_2_Q2_USD":203155000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q2_USD":40000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":4516000.0,"AssetsCurrent_0_Q2_USD":666640000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_2_Q2_USD":381784000.0,"ProceedsFromIssuanceOfLongTermDebt_2_Q2_USD":1000000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":18769495.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":2742000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_2_Q2_USD":9221000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":4423000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_2_Q2_USD":320151000.0,"CommonStockSharesIssued_0_Q2_shares":154799721.0,"StockIssuedDuringPeriodValueNewIssues_1_Q2_USD":160270000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q2_USD":-63000.0,"Liabilities_0_Q2_USD":108377000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":46843000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":5418000.0,"ResearchAndDevelopmentExpense_2_Q2_USD":118068000.0,"ResearchAndDevelopmentExpense_1_Q2_USD":62119000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":98403000.0,"EarningsPerShareBasic_2_Q2_USD":-1.04,"EarningsPerShareBasic_1_Q2_USD":-0.53,"AssetsFairValueDisclosure_0_Q2_USD":682989000.0,"IncreaseDecreaseInAccruedLiabilities_2_Q2_USD":-10523000.0,"LettersOfCreditOutstandingAmount_0_Q2_USD":1000000.0,"CommonStockValue_0_Q2_USD":7000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":46288000.0,"LongTermNotesPayable_0_Q2_USD":1000000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_2_Q2_USD":31355000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardCompensationCost1_1_Q2_USD":14414000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":738000.0,"AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate_0_Q2_USD":619893000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q2_pure":0.0,"EffectiveIncomeTaxRateContinuingOperations_2_Q2_pure":0.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":214346000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_0_Q2_USD":573605000.0,"RestrictedCash_0_Q2_USD":6084000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-156786000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-81414000.0,"AccruedEmployeeBenefitsCurrent_0_Q2_USD":10210000.0,"IncreaseDecreaseInAccountsPayable_2_Q2_USD":4950000.0,"OtherAssetsNoncurrent_0_Q2_USD":1150000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":82763000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q2_USD":619893000.0,"Assets_0_Q2_USD":852790000.0,"ShareBasedCompensation_2_Q2_USD":31355000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":52508000.0,"EarningsPerShareDiluted_2_Q2_USD":-1.04,"EarningsPerShareDiluted_1_Q2_USD":-0.53,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q2_USD":6316000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q2_USD":73000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_2_Q2_USD":31355000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":14414000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-116399000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":4775000.0,"LiabilitiesCurrent_0_Q2_USD":60534000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect_2_Q2_USD":15993000.0,"AccountsPayableCurrent_0_Q2_USD":21914000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q2_USD":88847000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":10272000.0,"ProceedsFromStockOptionsExercised_2_Q2_USD":10191000.0,"OtherAccruedLiabilitiesCurrent_0_Q2_USD":1793000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.075,"SecurityDeposit_0_Q2_USD":1450000.0,"ShortTermLeaseCost_2_Q2_USD":75000.0,"ShortTermLeaseCost_1_Q2_USD":39000.0,"AdditionalPaidInCapital_0_Q2_USD":1731363000.0,"CashEquivalentsAtCarryingValue_0_Q2_USD":63096000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_2_Q2_USD":970000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":970000.0,"OperatingLeasePayments_2_Q2_USD":4834000.0,"OperatingLeasePayments_1_Q2_USD":2512000.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":80120000.0,"NetIncomeLoss_2_Q2_USD":-156800000.0,"CommonStockSharesOutstanding_0_Q2_shares":154799721.0,"ShortTermInvestments_0_Q2_USD":573605000.0,"LeaseCost_1_Q2_USD":4997000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-986993000.0,"ProceedsFromIssuanceOfCommonStock_2_Q2_USD":203155000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_2_Q2_USD":24.38,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":47132000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":4372000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-8159000.0,"CommonStockSharesAuthorized_0_Q2_shares":300000000.0,"OperatingIncomeLoss_2_Q2_USD":-156996000.0,"OperatingIncomeLoss_1_Q2_USD":-81426000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":573605000.0,"AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDateAmortizedCostBasis_0_Q2_USD":619860000.0,"InvestmentIncomeInterest_2_Q2_USD":196000.0,"InvestmentIncomeInterest_1_Q2_USD":75000.0,"OperatingLeaseCost_2_Q2_USD":6777000.0,"OperatingLeaseCost_1_Q2_USD":3380000.0,"LiabilitiesAndStockholdersEquity_0_Q2_USD":852790000.0,"AmortizationOfDebtDiscountPremium_2_Q2_USD":3862000.0,"PropertyPlantAndEquipmentGross_0_Q2_USD":86436000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":4428000.0,"OperatingExpenses_2_Q2_USD":156996000.0,"OperatingExpenses_1_Q2_USD":81426000.0,"StockholdersEquity_0_Q2_USD":744413000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":20321000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q2_USD":619860000.0,"LongTermInvestments_0_Q2_USD":46288000.0,"VariableLeaseCost_2_Q2_USD":2288000.0,"VariableLeaseCost_1_Q2_USD":1578000.0,"LeaseCost_2_Q2_USD":9140000.0,"ConversionOfStockAmountConverted1_2_Q2_USD":1000.0,"Ticker":"IOVA","CIK":"1425205","name":"IOVANCE BIOTHERAPEUTICS, INC.","OfficialName":"Iovance Biotherapeutics Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"2593277297.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]